Edition:
India

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

4.35USD
23 Jan 2018
Change (% chg)

$0.45 (+11.54%)
Prev Close
$3.90
Open
$4.20
Day's High
$4.50
Day's Low
$4.15
Volume
115,317
Avg. Vol
10,513
52-wk High
$4.50
52-wk Low
$2.28

Chart for

About

Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization,... (more)

Overall

Beta: 1.14
Market Cap(Mil.): $130.63
Shares Outstanding(Mil.): 34.84
Dividend: --
Yield (%): --

Financials

BRIEF-Harvard Bioscience To Acquire Data Sciences International

* HARVARD BIOSCIENCE TO ACQUIRE DATA SCIENCES INTERNATIONAL AND SELLS DENVILLE SCIENTIFIC

23 Jan 2018

BRIEF-Harvard Bioscience reports Q3 loss $0.01/shr

* Harvard Bioscience reports third quarter 2017 financial results

27 Oct 2017

BRIEF-Harvard Bioscience appoints Katherine Eade, Thomas Loewald to board

* Harvard Bioscience appoints Katherine Eade and Thomas Loewald to the board of directors Source text for Eikon: Further company coverage:

26 Oct 2017

Earnings vs. Estimates